Stability of lorazepam 1 and 2 mg/mL in glass bottles and polypropylene syringes

American Journal of Health-System Pharmacy

Volumn 55, Issue 19, 1998, Pages 2013-2015

  Share, Michael J ^a   Harrison, Robert D ^b,c   Folstad, Joyce ^c   Fleming, Ronald A ^d  

^a North Carolina Baptist Hospital   (United States)

^b Olsten Health Services   (United States)

^c NCBH

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLASS; LORAZEPAM; POLYPROPYLENE;

DRUG STABILITY; GLASS BOTTLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NOTE; PRIORITY JOURNAL; SYRINGE;

EID: 0032189733     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.19.2013     Document Type: Note

References (13)

1. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized Study. Crit Care Med. 1994; 22:1241-7.
2. Boullata JI, Gelone SP, Mancano MA et al. Precipitation of lorazepam infusion. Ann Pharmacother. 1996; 30:1037-8. Letter.
3. Volles DF. More on usability of lorazepam admixtures for continuous infusion. Am J Health-Syst Pharm. 1996; 53:2753-4. Letter.
4. Boullata JI, Gelone SP. More on usability of lorazepam admixtures for continuous infusion. Am J Health-Syst Pharm. 1996; 53:2754. Letter.
5. Nahata MC, Morosco RS, Hipple TF. Stability of lorazepam diluted in bacteriostatic water for injection at two temperatures. J Clin Pharm Ther. 1993; 18:69-71.
6. Mancano MA, Boullata JI, Gelone SP et al. Availability of lorazepam after simulated administration from glass and polyvinyl chloride containers. Am J Health-Syst Pharm. 1995; 52:2213-6.
7. Hoey LL, Vance-Bryan K, Clarens DM et al. Lorazepam stability in parenteral solutions for continuous intravenous administration. Ann Pharmacother. 1996; 30:343-6.
8. Trissel LA, Pearson SD. Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags. Am J Hosp Pharm. 1994; 51:368-72.
9. Stiles ML, Allen LV, Prince SJ. Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes. Am J Health-Syst Pharm. 1996; 53: 1583-8.
10. Ativan package insert. Philadelphia: Wyeth Laboratories; 1995 Feb.
11. Budavari S, ed. The Merck index. 11th ed. Rahway, NJ: Merck & Co.; 1989.
12. Laine GA, Hossain SMH, Solis RT et al. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother. 1995; 29:1110-4.
13. Seay RE, Graves PJ, Wilkin MK. Comment: possible toxicity from propylene glycol in lorazepam infusion. Ann Pharmacother. 1997; 31:647-8.